Hvsen Biotechnology Co., Ltd. (300871.SZ)
CNY 21.48
(-2.27%)
CNY 21.48
(-2.27%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 209.8 Million CNY | -5.36% |
| 2022 | 225.36 Million CNY | -16.75% |
| 2021 | 270.72 Million CNY | -5.96% |
| 2020 | 287.87 Million CNY | 75.89% |
| 2019 | 163.66 Million CNY | -10.92% |
| 2018 | 183.72 Million CNY | -9.36% |
| 2017 | 202.7 Million CNY | 49.28% |
| 2016 | 135.78 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 44.56 Million CNY | -33.12% |
| 2024 Q3 | 44.66 Million CNY | 107.63% |
| 2024 Q2 | 22.8 Million CNY | -48.82% |
| 2023 Q1 | 55.71 Million CNY | -36.7% |
| 2023 FY | 213.29 Million CNY | -5.36% |
| 2023 Q4 | 66.63 Million CNY | 43.86% |
| 2023 Q3 | 46.31 Million CNY | 3.77% |
| 2023 Q2 | 44.63 Million CNY | -19.88% |
| 2022 Q2 | 34.79 Million CNY | -16.12% |
| 2022 FY | 225.36 Million CNY | -16.75% |
| 2022 Q1 | 41.48 Million CNY | 7.66% |
| 2022 Q3 | 61.06 Million CNY | 75.49% |
| 2022 Q4 | 88 Million CNY | 44.12% |
| 2021 Q4 | 38.53 Million CNY | -29.05% |
| 2021 FY | 270.72 Million CNY | -5.96% |
| 2021 Q3 | 54.31 Million CNY | -26.48% |
| 2021 Q1 | 104 Million CNY | 2.98% |
| 2021 Q2 | 73.87 Million CNY | -28.97% |
| 2020 FY | 287.87 Million CNY | 75.89% |
| 2020 Q4 | 100.99 Million CNY | 31.05% |
| 2020 Q3 | 77.06 Million CNY | 33.63% |
| 2020 Q2 | 57.66 Million CNY | 10.6% |
| 2020 Q1 | 52.14 Million CNY | -16.07% |
| 2019 Q3 | 30.46 Million CNY | 0.0% |
| 2019 Q4 | 62.12 Million CNY | 103.9% |
| 2019 FY | 163.66 Million CNY | -10.92% |
| 2018 FY | 183.72 Million CNY | -9.36% |
| 2017 FY | 202.7 Million CNY | 49.28% |
| 2016 FY | 135.78 Million CNY | 0.0% |